GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » YoY EBITDA Growth

Braxia Scientific (XCNQ:BRAX) YoY EBITDA Growth : 66.67% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Braxia Scientific YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Braxia Scientific's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 66.67%.

Braxia Scientific's EBITDA per Share for the three months ended in Dec. 2023 was C$-0.00.

Braxia Scientific YoY EBITDA Growth Historical Data

The historical data trend for Braxia Scientific's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Braxia Scientific YoY EBITDA Growth Chart

Braxia Scientific Annual Data
Trend Mar21 Mar22 Mar23
YoY EBITDA Growth
- 87.74 18.84

Braxia Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.00 11.43 40.00 85.71 66.67

Braxia Scientific YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Braxia Scientific's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EBITDA Growth (A: Mar. 2023 )
=(EBITDA per Share (A: Mar. 2023 )-EBITDA per Share (A: Mar. 2022 ))/ | EBITDA per Share (A: Mar. 2022 ) |
=(-0.056--0.069)/ | -0.069 |
=18.84 %

Braxia Scientific's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.003--0.009)/ | -0.009 |
=66.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Braxia Scientific YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Braxia Scientific's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Braxia Scientific Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Braxia Scientific Corp (XCNQ:BRAX) » Definitions » YoY EBITDA Growth
Comparable Companies
XCNQ:MBIO XCNQ:NOVA TSX:APLI TSXV:IOT XCNQ:MESC XCNQ:BIOV XCNQ:GLOW TSXV:RP TSXV:MRVL TSX:IPCI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
BRAXF:USA 4960:Germany
Address
700 Bay Street, Suite 1903, Toronto, ON, CAN, M5G 1Z6
Website
https://www.braxiascientific.com
Braxia Scientific Corp is a research-driven medical solutions company that aims to reduce the illness burden of brain-based mental disorders such as depressive disorder among others. It is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. The company develops ketamine and psilocybin derivatives and other psychedelic products from its IP development platform.

Braxia Scientific Headlines

No Headlines